ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus-Reference-Cited by-同舟云学术

ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus

Published:2018-10 Issue:10 Volume:42 Page:1353-1359
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Mohammad Nissreen,Haimes Josh D.,Mishkin Skyler,Kudlow Brian A.,Leong May Ying,Chew Sung Hock,Koay Eleanor,Whitehouse Ann,Cope Nichola,Ali Rola H.,Köbel Martin,Stewart Colin J.R.,McCluggage W. Glenn,Lee Cheng-Han

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference22 articles.

1. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors;Rabban;Am J Surg Pathol,2005

2. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract;Fuehrer;Arch Pathol Lab Med,2012

3. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course;Parra-Herran;Am J Surg Pathol,2015

4. Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1;Haimes;Am J Surg Pathol,2017

5. Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: a low threshold for ALK immunohistochemistry is required;Pickett;Am J Surg Pathol,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Perspectives in the Treatment of Inflammatory Myofibroblastic Tumor with ALK Translocation: Case Report;Case Reports in Oncology;2024-07-20

2. A diagnostic dilemma—to operate or not to operate—a rare case report;Journal of Surgical Case Reports;2024-05

3. The “Other” Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities;Advances in Anatomic Pathology;2024-04-16

4. Uncommon Uterine Mesenchymal Neoplasms and Mixed Epithelial-Mesenchymal Lesions;Gynecologic and Obstetric Pathology;2024

5. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases;Modern Pathology;2023-09